Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001055726-25-000040
Filing Date
2025-05-21
Accepted
2025-05-21 16:58:38
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747861110.html 4  
1 FORM 4 wk-form4_1747861110.xml 4 5169
  Complete submission text file 0001055726-25-000040.txt   7001
Mailing Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462
Business Address 660 W. GERMANTOWN PIKE SUITE 110 PLYMOUTH MEETING PA 19462 8584103134
INOVIO PHARMACEUTICALS, INC. (Issuer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 334 CR 692 BUFFALO GAP TX 79508
Business Address
Zoth Lota S. (Reporting) CIK: 0001278219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14888 | Film No.: 25973800